LU87262A1 - Nouveaux derives de la somatostatine,leur preparation et leur utilisation comme medicaments - Google Patents

Nouveaux derives de la somatostatine,leur preparation et leur utilisation comme medicaments Download PDF

Info

Publication number
LU87262A1
LU87262A1 LU87262A LU87262A LU87262A1 LU 87262 A1 LU87262 A1 LU 87262A1 LU 87262 A LU87262 A LU 87262A LU 87262 A LU87262 A LU 87262A LU 87262 A1 LU87262 A1 LU 87262A1
Authority
LU
Luxembourg
Prior art keywords
residue
signifies
hydrogen
formula
group
Prior art date
Application number
LU87262A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of LU87262A1 publication Critical patent/LU87262A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Hospice & Palliative Care (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU87262A 1987-06-29 1988-06-28 Nouveaux derives de la somatostatine,leur preparation et leur utilisation comme medicaments LU87262A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3721406 1987-06-29
DE3721407 1987-06-29
DE3721406 1987-06-29
DE3721407 1987-06-29

Publications (1)

Publication Number Publication Date
LU87262A1 true LU87262A1 (fr) 1989-03-08

Family

ID=25857047

Family Applications (1)

Application Number Title Priority Date Filing Date
LU87262A LU87262A1 (fr) 1987-06-29 1988-06-28 Nouveaux derives de la somatostatine,leur preparation et leur utilisation comme medicaments

Country Status (15)

Country Link
JP (1) JPS6426599A (hr)
KR (1) KR890000520A (hr)
AU (1) AU1840988A (hr)
BE (1) BE1002663A4 (hr)
CH (1) CH679045A5 (hr)
DK (1) DK353788A (hr)
ES (1) ES2010283A6 (hr)
FR (1) FR2617171B1 (hr)
GB (1) GB2206352B (hr)
IL (1) IL86876A0 (hr)
IT (1) IT1221065B (hr)
LU (1) LU87262A1 (hr)
NL (1) NL8801640A (hr)
NZ (1) NZ225188A (hr)
SE (1) SE8802413L (hr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU906341D0 (en) * 1986-10-13 1991-04-29 Sandoz Ag Process for producing peptonic derivatives modified with sugar and pharmaceutical preparatives containing these compounds as active substance
GB8826452D0 (en) * 1988-11-11 1988-12-14 Sandoz Ltd Peptide derivatives
GB8813339D0 (en) * 1988-06-06 1988-07-13 Sandoz Ltd Improvements in/relating to organic compounds
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
US5776894A (en) * 1988-12-05 1998-07-07 Novartis Ag Chelated somatostatin peptides and complexes thereof, pharmaceutical compositions containing them and their use in treating tumors
US5753627A (en) * 1988-12-05 1998-05-19 Novartis Ag Use of certain complexed somatostatin peptides for the invivo imaging of somatostatin receptor-positive tumors and metastasis
JP2882679B2 (ja) * 1989-04-26 1999-04-12 ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド 線状ソマトスタチン類似体
US5633263A (en) * 1989-04-26 1997-05-27 The Administrators Of The Tulane Educational Fund Linear somatostatin analogs
GB9004017D0 (en) * 1990-02-22 1990-04-18 Krenning Eric P Improvements in or relating to organic compounds
US5632969A (en) * 1994-10-13 1997-05-27 Merck & Co., Inc. N3 S2 chelating ligands optionally radiolabelled with Tc or Re, useful for diagnostic or therapeutic applications
US5556939A (en) * 1994-10-13 1996-09-17 Merck Frosst Canada, Inc. TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications
AUPN999096A0 (en) * 1996-05-22 1996-06-13 Northstar Biologicals Pty Ltd Peptides, antibodies, vaccines & uses thereof
ATE291587T1 (de) * 2000-07-31 2005-04-15 Dabur Res Foundation Somatostatin analoge und deren verwendung zur behandlung von krebs
RU2263678C2 (ru) 2001-03-08 2005-11-10 Дзе Администрейторс Оф Дзе Тьюлейн Эдьюкейшнл Фанд Антагонисты соматостатина
KR20030088494A (ko) * 2001-04-09 2003-11-19 더 어드미니스트레이터즈 오브 더 튜래인 어듀케이셔널 훤드 소마토스타틴 작용제
KR100432178B1 (ko) * 2002-01-29 2004-05-22 홍수천 철제배관의 부식방지능을 갖는 수정화 장치
KR100462968B1 (ko) * 2002-06-10 2004-12-23 주식회사 리독스 배관내의 물의 살균, 악취제거 및 스케일 발생 방지를위한 수처리 장치

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU85269A1 (fr) * 1984-03-26 1985-10-14 Techland S A Composes nouveaux de somatostatine,procede pour leur synthese,preparation a usage veterinaire contenant lesdits composes et procede pour le traitement d'animaux
HUT42101A (en) * 1985-01-07 1987-06-29 Sandoz Ag Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds

Also Published As

Publication number Publication date
IT8848133A0 (it) 1988-06-28
JPS6426599A (en) 1989-01-27
CH679045A5 (hr) 1991-12-13
DK353788A (da) 1988-12-30
GB8815257D0 (en) 1988-08-03
SE8802413D0 (sv) 1988-06-28
SE8802413L (sv) 1988-12-30
KR890000520A (ko) 1989-03-15
NZ225188A (en) 1991-04-26
AU1840988A (en) 1989-01-05
FR2617171A1 (fr) 1988-12-30
BE1002663A4 (fr) 1991-04-30
GB2206352A (en) 1989-01-05
DK353788D0 (da) 1988-06-27
GB2206352B (en) 1990-10-31
NL8801640A (nl) 1989-01-16
IL86876A0 (en) 1988-11-30
IT1221065B (it) 1990-06-21
FR2617171B1 (fr) 1994-10-14
ES2010283A6 (es) 1989-11-01

Similar Documents

Publication Publication Date Title
LU87262A1 (fr) Nouveaux derives de la somatostatine,leur preparation et leur utilisation comme medicaments
BE1003752A4 (fr) Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments.
EP0679161B1 (fr) Derives de thiazolidine, leur preparation et les medicaments les contenant
FR2501199A1 (fr) Nouveaux polypeptides, leur preparation et leur application comme medicaments
FR2515188A1 (fr) Nouveaux derives du 3-amino-pregn-5-ene, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
FR2667864A2 (fr) Derives de n-phenyl glycinamides, leur preparation et les medicaments les contenant.
BE1004038A4 (fr) Nouvelle utilisation therapeutique d'analogues ou de derives de la somatostatine.
CH634041A5 (fr) Derives de la pepstatine, leur preparation et composition les contenant.
US3843796A (en) Antihypertensive agents
EP0005658A1 (fr) Nouveaux dérivés de peptides analogues des enképhalines, leur procédé de préparation et leur application thérapeutique
BE897546A (fr) Nouveaux polypeptides leur preparation et leur application comme medicaments
LU82568A1 (fr) Nouveaux dipeptides,leur preparation et les medicaments qui les contiennent
FR2548187A1 (fr) Composes d'organo-germanium et leurs utilisations therapeutiques en tant qu'inhibiteurs des enzymes qui degradent les peptides opioides
FR2489320A1 (fr) Nouveaux peptides anorexigenes
EP1140981B1 (fr) Composes tripeptidiques utiles a titre d'inhibiteurs selectifs de l'aminopeptidase a et compositions pharmaceutiques correspondantes
CN1064681C (zh) 杂环化合物
EP0759934B1 (fr) Peptides antagonistes de la neurotensine
FR2721021A1 (fr) Nouveaux inhibiteurs de farnésyl transférase, leur préparation et les compositions pharmaceutique qui les contiennent.
FR2522655A1 (fr) Analogues de la somatostatine possedant une liaison du type hydrazide et medicaments en contenant
CH647789A5 (fr) Tripeptides, leur preparation et les medicaments qui les contiennent.
BE893553A (fr) Derives de la proline et procede pour les preparer
KR880002594B1 (ko) 트리펲타이드를 함유한 n-카르복시알킬프롤린을 제조하는 방법
CA1113458A (en) Phenylglycine derivatives
BE839405A (fr) Nouveaux polypeptides, leur preparation et leur application comme medicaments
JPH06234630A (ja) 中性メタロエンドペプチダーゼ阻害剤

Legal Events

Date Code Title Description
DT Application date
TA Annual fee